With this engagement, the Straumann Biomaterials department underlines once again that the collaboration with dental professionals for research and innovation is a hallmark of our success.
From the publications submitted for evaluation, an independent jury chose as winner the human randomized controlled trial with the theme "Consumption of Lactobacillus reuteri-containing lozenges improves periodontal health in navy sailors at sea: A randomized controlled trial". The study was conducted by Ulrich Schlagenhauf (Department of Periodontology, University Hospital Wuerzburg, Wuerzburg, Germany), Juliane Rehder (German Naval Medical Institute, Kronshagen, Germany), Götz Gelbrich (Institute of Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany) and Yvonne Jockel-Schneider (Department of Periodontology, University Hospital Wuerzburg, Wuerzburg, Germany).
On behalf of Straumann®, Laurentiu Motoc (Global Product Manager Biomaterials) and Dr. Dominic Birth (Product Manager Biomaterials Germany) handed over the prize and congratulated the winning team represented on site by Prof. Dr. Schlagenhauf.
From left to right: Prof. Dr. Bettina Dannewitz (President DG PARO), Laurentiu Motoc (Straumann Headquaters), Prof. Dr. Schlagenhauf, Dr. Dominic Birth (Straumann Germany).
DG PARO's annual event kicked off on September 11th, 2020 in a unique hybrid format, adapted to the current challenges. German dentists interested in periodontics were able to interact in front of home screens or via in-person meetings, in Stuttgart - Germany. The key messages of the main lectures were presented live and as a stream for everyone who participated from home. DG PARO, congratulations for staging the event in maximum safety conditions!
Our unique biologics, complete GBR portfolio and innovative custom solutions are designed to help our customers master the challenges they might face in their daily practice. If you lile to learn more: click here.
